Gene Transfer, Targeting
and Therapeutics Core

People

Salk Institute for Biological Studies - Gene Transfer, Targeting
and Therapeutics Core - People

Facility Staff


John Naughton

Managing Director - GT3 Core

As Managing Director of the Gene Transfer, Targeting and Therapeutics Facility at the Salk Institute, John Naughton’s main focus is on providing comprehensive resources to facilitate the safe and effective use of viral and non-viral gene transfer technologies to study critical problems in all aspects of biological research.

John Naughton is experienced with HIV research and has a background in gene delivery and targeting using multiple viral-vector systems. He provides management and oversight for all GT3 Core resources and is the primary point of contact for any inquiries regarding core services or resources.

John Marlett

Research Assistant - GT3 Core

As the senior Research Assistant for the Salk Institute GT3 Core, John Marlett assist with all aspects of virus production and assuring smooth core operations. He has a particular focus on the production of modified rabies, high-titer custom lentiviral, retroviral, adenoviral and rAAV vectors for multiple investigators.

Raul Armendariz

Research Assistant - GT3 Core

As a Research Assistant for the Salk Institute GT3 Core, Raul Armendariz is responsible for producing rabies, lentiviral, retroviral and rAAV vectors stocks for the core. He is also in charge of GT3 plasmid bank as well as for cloning of new constructs and packaging those into vector stocks.

Raul graduated from the University of California, San Diego with a B.S. in Human Biology, and joined the GT3 Core in July 2013. He plans to pursue his interests in mircobiology by attending graduate school.